Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
International Journal of Molecular Sciences · 27.01.2025 · 26 (3) · 1094
DOI: 10.3390/ijms26031094 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.01.2025. Verfasst von Ewelina Młynarska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Complications. Die Arbeit wurde bisher 375-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes mellitus (T2DM), a prevalent chronic disease affecting over 400 million people globally, is driven by genetic and environmental factors. The pathogenesis involves insulin resistance and β-cell dysfunction, mediated by mechanisms such as the dedifferentiation of β-cells, mitochondrial dysfunction, and oxidative stress. Treatment should be based on non-pharmacological therapy. Strategies such as increased physical activity, dietary modifications, cognitive-behavioral therapy are important in maintaining normal glycemia. Advanced therapies, including SGLT2 inhibitors and GLP-1 receptor agonists, complement these treatments and offer solid glycemic control, weight control, and reduced cardiovascular risk. Complications of T2DM, such as diabetic kidney disease, retinopathy, and neuropathy, underscore the need for early diagnosis and comprehensive management to improve patient outcomes and quality of life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrocardiology, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland.
- Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, Ul. Zeromskiego 113, 90-549 Lodz, Poland.
ORCID-Profile: Witold Czarnik, Gabriela Majchrowicz, Magdalena Stabrawa
Zitieren
APA
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025). Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. International Journal of Molecular Sciences, 26(3), 1094. https://doi.org/10.3390/ijms26031094
Vancouver
Młynarska E, Czarnik W, Dzieża N, Jędraszak W, Majchrowicz G, Prusinowski F, et al. Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications. International Journal of Molecular Sciences. 2025;26(3):1094. doi:10.3390/ijms26031094
BibTeX
@article{Mynarska2025,
author = {Młynarska, Ewelina and Czarnik, Witold and Dzieża, Natasza and Jędraszak, Weronika and Majchrowicz, Gabriela and Prusinowski, Filip and Stabrawa, Magdalena and Rysz, Jacek and Franczyk, Beata},
title = {Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {3},
pages = {1094},
doi = {10.3390/ijms26031094}
}
EUVIMED